The "smart" pill bottle provides physicians and pharmacists with a solution that ensures patients adhere to medications as prescribed, preventing medical problems such as prolonged illness, increased hospitalization and overdosing.
Read MoreIntroduces the concept of "Evidence Fluency" as a solution to the current crisis and a path towards improving healthcare overall
Read More
With Northway Biotech's expertise in biologics manufacturing, Mallia aims to enter the multi-billion-dollar alopecia market by delivering a safe and effective topical sCD83 treatment designed to stimulate hair follicle formation and promote sustained hair growth.
Read More
EnvisionOne Vantage enables medical affairs professionals to benchmark their publication performance against other companies, providing crucial competitive intelligence and valuable insights for strategic adjustments to publication strategies.
Read More
Funding from the NIH's National Institute on Drug Abuse (NIDA) will Support Development of ENA-001, an Agnostic Respiratory Stimulant, for Community Drug Overdose and as a Medical Countermeasure
Read MoreOxidative stress drives aging and is a key factor in diseases like Alzheimer's, Age-related Macular Degeneration (AMD), cardiovascular diseases, cancer, and diabetes. It also plays a critical role in the progression of viral infections, such as avian influenza (bird flu), by exacerbating inflammation and cellular damage. Directly addressing oxidative stress and its consequences is essential to treating the underlying causes of these conditions and mitigating the severity of viral outbreaks.
Read MoreDuty Free Meds is proud to introduce a new Zepbound coupon offering to help lower patient costs associated with the weight-loss medication. These coupons can help customers spend less on weight-loss drugs and other medications.
Read More
The interview with Dr. John Barr and Jim Patton tackles medication safety and how PillSafe Technologies secures prescriptions, prevents abuse, and protects patients and doctors, leading the fight against the opioid crisis.
Read MoreTransaction follows a $5 million non-dilutive credit line from the same trusted partner, further reinforcing Telomir's financial strength and growth potential.
Read MoreBuilding on preclinical success demonstrating age reversal, longevity, and increased healthspan, Telomir-1 appears to address insulin resistance at its root, achieving reversal to near pre-diabetic levels
Read More